<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on MedImmune from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated MedImmune news from BioPortfolio.com</description>
	<pubDate>Tue, 09 Feb 2010 23:15:59 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=MedImmune" rel="self" type="application/rss+xml" />

	
<item><title>AstraZeneca still waiting for the upside to MedImmune acquisition</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033333&amp;HITNO=0&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033333&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535143823%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033333&amp;HITNO=0&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033333&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535143823%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Charlotte Business Journal:</description></item>
<item><title>AstraZeneca still waiting for the upside to MedImmune acquisition</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4028062&amp;HITNO=1&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4028062&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532560322%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4028062&amp;HITNO=1&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4028062&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532560322%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Biz Journals:</description></item>
<item><title>AstraZeneca still waiting for the upside to MedImmune acquisition</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4027554&amp;HITNO=2&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4027554&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532242138%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4027554&amp;HITNO=2&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4027554&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532242138%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Journal of Jacksonville:</description></item>
<item><title>MedImmune, Inc. (formerly Cambridge Antibody Technology)-Company Report - new market report released</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4027384&amp;HITNO=3&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4027384&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532116041%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4027384&amp;HITNO=3&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4027384&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532116041%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR inside:</description></item>
<item><title>Activists Increasingly Like Biotechs But With Mixed Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4031213&amp;HITNO=4&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4031213&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534065489%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4031213&amp;HITNO=4&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4031213&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534065489%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FOXBusiness.com:</description></item>
<item><title>Activists Increasingly Like Biotechs But With Mixed Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4031070&amp;HITNO=5&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4031070&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533972898%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4031070&amp;HITNO=5&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4031070&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533972898%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Morningstar.com:</description></item>
<item><title>Activists Increasingly Like Biotechs But With Mixed Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4031036&amp;HITNO=6&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4031036&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533949023%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4031036&amp;HITNO=6&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4031036&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533949023%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Nasdaq:</description></item>
<item><title>AstraZeneca still waiting for the upside to MedImmune acquisition</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4024822&amp;HITNO=7&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4024822&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529209832%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4024822&amp;HITNO=7&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4024822&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529209832%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>San Francisco Business Times:</description></item>
<item><title>Health Dept. announces third H1N1 vaccine recall</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4024644&amp;HITNO=8&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4024644&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529031813%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4024644&amp;HITNO=8&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4024644&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2529031813%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News Sun:</description></item>
<item><title>Swine flu still out there, officials caution</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4023934&amp;HITNO=9&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4023934&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528495485%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4023934&amp;HITNO=9&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4023934&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528495485%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Reuters Health:</description></item>
<item><title>AstraZeneca still waiting for the upside to MedImmune acquisition</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4021440&amp;HITNO=10&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4021440&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2527228128%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4021440&amp;HITNO=10&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4021440&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2527228128%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Washington Business Journal:</description></item>
<item><title>FDA balks on MedImmune's cell-grown flu vaccine</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4023165&amp;HITNO=11&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4023165&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528063830%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4023165&amp;HITNO=11&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4023165&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2528063830%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Nature Biotechnology:</description></item>
<item><title>Swine flu still out there, officials caution</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4022973&amp;HITNO=12&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4022973&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2527966803%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4022973&amp;HITNO=12&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4022973&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2527966803%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Reuters UK:</description></item>
<item><title>Greenleaf named MedImmune president</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4009772&amp;HITNO=13&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4009772&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522087840%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4009772&amp;HITNO=13&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4009772&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522087840%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Frederick News-Post:</description></item>
<item><title>Micromet to Host Annual Research &amp; Development Day on February 10, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013115&amp;HITNO=14&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013115&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523615172%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013115&amp;HITNO=14&amp;MSIZE=394&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=MedImmune&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013115&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523615172%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
</channel></rss>